logowsbdaily | Tue, 20 Dec 2022 03:11:26 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Helius Medical Technologies, Inc.
(HSDT)

Helius Medical Technologies, Inc.
642 Newtown Yardley Road
Suite 100
Newtown, PA 18940
United States
215 944 6100
heliusmedical.com
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunctio... Read More

Summary & Charts

Price$ 0.35+0.04 (+12.9%)
Day's Range$ 0.30 - 0.37 
Previous Close$ 0.31
Market Cap$ 7.48M USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqCM
IndustryMedical Devices
SectorHealthcare
Volume3.27M
Avg. Volume (20 day)799.52K
Rel. Volume (20 day)4.09
Rel. Volume (3 month)1.30
RatingB+Neutral
DCFN/AStrong Buy
Debt/Equity45.51 %Neutral
ROE-148.27 %Neutral
ROA-71.13 %Neutral
P/E-0.05 %Sell
P/B0.23 %Neutral
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Nov 17, 2022$ 0.31$ 0.37$ 0.30$ 0.35+0.043,271,0284.091.30
Nov 16, 2022$ 0.30$ 0.38$ 0.27$ 0.31+0.046,787,41810.352.631
Nov 15, 2022$ 0.30$ 0.30$ 0.25$ 0.27-0.02367,4211.130.14
Nov 14, 2022$ 0.30$ 0.31$ 0.28$ 0.29+0.031,004,1593.060.35
Nov 11, 2022$ 0.26$ 0.27$ 0.25$ 0.26+0.01266,2130.850.09
Nov 10, 2022$ 0.24$ 0.26$ 0.23$ 0.25+0.01398,9081.260.12
Nov 09, 2022$ 0.25$ 0.27$ 0.24$ 0.24-0.02535,3661.700.13
Nov 08, 2022$ 0.28$ 0.28$ 0.25$ 0.25-0.01199,5950.660.05
Nov 07, 2022$ 0.27$ 0.28$ 0.26$ 0.26-0.01280,7820.880.07
Nov 04, 2022$ 0.28$ 0.29$ 0.27$ 0.28-0.01386,6031.160.10
Nov 03, 2022$ 0.27$ 0.29$ 0.27$ 0.28+0.00167,8090.490.05
Nov 02, 2022$ 0.27$ 0.29$ 0.27$ 0.28+0.00294,7120.790.08
Nov 01, 2022$ 0.28$ 0.28$ 0.28$ 0.28-0.0079,7040.200.02
Oct 31, 2022$ 0.26$ 0.29$ 0.26$ 0.28+0.00229,6460.530.06
Oct 28, 2022$ 0.28$ 0.30$ 0.26$ 0.27-0.01368,2310.800.10
Oct 27, 2022$ 0.28$ 0.28$ 0.27$ 0.28-0.00201,8180.420.05
Oct 26, 2022$ 0.28$ 0.30$ 0.26$ 0.28+0.01391,5110.790.10
Oct 25, 2022$ 0.24$ 0.27$ 0.24$ 0.27+0.02384,0660.740.10
Oct 24, 2022$ 0.25$ 0.26$ 0.24$ 0.25-0.00163,9650.280.04
Oct 21, 2022$ 0.26$ 0.26$ 0.25$ 0.25-0.01211,4510.340.05

News

The latest news about Helius Medical Technologies, Inc. (HSDT).

Zacks Investment Research | 2022-11-17 13:32:25
Helius Medical Technologies, Inc. (HSDT) Moves to Buy: Rationale Behind the Upgrade
Helius Medical Technologies, Inc. (HSDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Seeking Alpha | 2022-11-14 10:45:03
Helius Medical Technologies, Inc. (HSDT) Q3 2022 Earnings Call Transcript
Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Dane Andreeff - President & Chief Executive Officer Jeff Mathiesen - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Jonathan Aschoff - ROTH Capital Partners Operator Good day, and thank you for standing by. Welcome to the Helius Medical Technologies Q3 2022 Earnings Call.
GlobeNewsWire | 2022-11-01 07:05:00
Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022
NEWTOWN, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the Company will release its third quarter 2022 financial results on Monday, November 14, 2022, before the market opens.
GlobeNewsWire | 2022-09-29 17:20:00
Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference
NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference, as follows:

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2022-11-14AMC-0.21-0.0385.72%170K196K15.29%
2022-08-15AMC-1.12-0.9713.4%------
2022-05-12AMC-1.13-1.151.76%187K190K1.8%
2022-03-14AMC-1.16-1.3112.93%160K258K61.25%
2021-11-10AMC-1.75-2.0114.85%93K109K17.45%
2021-08-12AMC-1.53-2.5868.62%55K71K28.79%
2021-05-17AMC------------
2020-11-12AMC-0.09----------

Top Discussions

These are the top discussions over the last 24-hours that mention the HSDT stock ticker symbol.


Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Thu, 9 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.